Craft
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
banner
PharmaEssentia financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.

Stock Price

NT$320

2024-03-27

Market Capitalization

NT$106.2 B

2024-03-27

Revenue

NT$15.6 B

FY, 2025

CreditSafe Score

?
Score changed on Jun 07, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn more

Financial Statements

TWDFY, 2018FY, 2019FY, 2020FY, 2021FY, 2022FY, 2023FY, 2024FY, 2025
Revenue26.2M305.7M557.3M656.5M2.9B5.1B9.7B15.6B
Cost of goods sold28.4M61.7M198.5M151.8M584.4M341.8M809.5M1.3B
Gross profit455.0K255.6M400.3M529.4M2.3B4.8B8.9B14.4B
Gross profit margin, %83.6%71.8%80.6%81.4%93.7%91.9%91.9%
Operating expense total994.2M955.8M1.9B3.1B4.1B6.4B6.8B9.0B
Depreciation and amortization58.5M137.4M174.8M227.1M227.9M268.8M367.7M398.6M
EBITDA(993.8M)(700.2M)(1.5B)(2.6B)(1.8B)(1.6B)2.1B5.3B
EBITDA margin, %-229.1%-269.1%-391.6%-60.8%-31.8%21.8%34.1%
EBIT(1.1B)(837.5M)(2.0B)(2.8B)(2.0B)(1.9B)1.7B4.9B
EBIT margin, %-274.0%-351.2%-427.1%-68.9%-37.2%17.6%31.5%
Interest income16.8M8.2M7.5M4.6M40.4M585.1M917.5M642.5M
Interest expense1.6M7.5M8.3M10.0M18.5M46.7M22.2M25.5M
Pre tax profit(1.0B)(842.1M)(1.9B)(2.8B)(1.8B)(986.9M)3.0B5.0B
Income tax expense592.0K850.0K126.0K(467.1M)(363.1M)29.1M(62.2M)
Net Income(1.0B)(843.0M)(1.9B)(2.8B)(1.4B)(623.8M)3.0B5.0B

Footer menu